Make scientific figures in minutes
Create publication-quality figures with pre-made icons and templates, all from BioRender's web-based software
Use Icons In The App
Try a synonym, or sign up to request an icon from the app.
AssayMAP cartridge (large)
[{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cd6/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cd6/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cd5/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cd5/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cd4/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cd4/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cd3/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cd3/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cd2/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cd2/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cd1/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cd1/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cd0/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cd0/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995ccf/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995ccf/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cce/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cce/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995ccd/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995ccd/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995ccc/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995ccc/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995ccb/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995ccb/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cca/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cca/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cc9/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cc9/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cc8/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cc8/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cc7/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cc7/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cc6/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cc6/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cc5/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cc5/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cc4/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cc4/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cc3/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cc3/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cc2/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cc2/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cc1/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cc1/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cc0/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cc0/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cbf/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cbf/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cbe/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cbe/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cbd/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cbd/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cbc/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cbc/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cbb/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cbb/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cba/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cba/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cb9/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cb9/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cb8/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cb8/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cb7/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cb7/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cb6/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cb6/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cb5/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cb5/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cb4/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cb4/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cb3/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cb3/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cb2/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cb2/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cb1/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cb1/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663665f145e0028995cb0/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663665f145e0028995cb0/5f4662d45f145e0028995caf.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5f4663745f145e0028995cd7/5f4662d45f145e0028995caf.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5f4663745f145e0028995cd7/5f4662d45f145e0028995caf.png"}]
Use this icon in BioRender along with 1000s of others to make your next science figure in minutes
.png)
SIGN UP FREEKeywords
Assaymap cartridge,platform,25 μL micro-litre,peptide sample,chromatography,pore,inlet seal,bed support,packed resin bed,slurry,single-pass contact,microplate liquid handling,assay
Image types
Related Categories
Join 1,500,000 other scientists on BioRender
Sign up for your free account and start creating scientific figures faster today
FAQs
What is BioRender?
Can I use this icon in a BioRender figure or scientific illustration?
